What Will Happen To This Marijuana Stock ?

Over the past few months, marijuana stocks declined in momentum following underwhelming financial results. In that time marijuana stock Aurora Cannabis (TSX:ACB) (NYSE:ACB) rose to new highs earlier this year but since then it has experienced a bit of churn. However, it could be time for this cannabis stock to make a bit of a comeback. As more and more investors come to realize that it is one of the handfuls of marijuana stocks to watch in the industry. This pot stock has demonstrated that it is one of the best in terms of product innovation and market research. In addition to the ability to ramp up production significantly. Moreover, the company’s impressive show in Q3 2019 should also prove to be a blessing for this marijuana stock.

Marijuana Production Capacity

As any expert know production capacity is one of the biggest factors in the growth of any cannabis company. This cannabis stock currently produces 150,000 kilos of cannabis a year but the capacity is going to rise considerably by 2020. The company is going to ramp up production across 15 operations and the total output is projected to be as much as 650,000 per year. Additionally, the company’s research and development are also primed to come up with a range of different products in the years to come. Currently, as many as 40 clinical studies are being conducted by Aurora and many investors will be looking forward to the results to know is this a marijuana stock to buy.

Is This Marijuana Stock a Buy or Sell

Over the years, Aurora has also managed to build up an excellent portfolio of both consumer and medical brands, through strategic acquisitions. Most of its brands have done well in Canada and the fact that its compounded revenue growth is now 566% since 2016, there is a compelling argument in favor of the Aurora stock. The next few quarters will certainly depict a clearer picture of its prospects.